Urothelial carcinoma bladder
Clinical trials for Urothelial carcinoma bladder explained in plain language.
Never miss a new study
Get alerted when new Urothelial carcinoma bladder trials appear
Sign up with your email to follow new studies for Urothelial carcinoma bladder, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on bladder cancer in early trial
Disease control Stopped earlyThis early-stage trial tests a new type of immunotherapy called 4SCAR-T cells in 20 people with advanced bladder cancer that has spread and no longer responds to standard treatments. The cells are genetically modified to recognize and attack cancer cells. The study aims to see if…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Hormone blocker added to chemo for bladder cancer: early study halted
Disease control Stopped earlyThis early study tested adding a testosterone-lowering drug (degarelix) to standard chemotherapy for people with muscle-invasive bladder cancer that has testosterone receptors. Only 2 people enrolled before the study was stopped. The goal was to see if the combination could elimi…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase 1 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC